PETER HIATT to Vaccines, Synthetic
This is a "connection" page, showing publications PETER HIATT has written about Vaccines, Synthetic.
Connection Strength
0.078
-
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60.
Score: 0.049
-
Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. Pediatr Infect Dis J. 1996 Jan; 15(1):23-31.
Score: 0.029